| Dir : /home/ithome/mail/cur/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/cur/1757611365.M911781P26931.host100322.itwesthosting.com,S=12075,W=12323:2, |
Return-Path: <editor@clincasereportintle.com>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id gA47NmUFw2gzaQAAp0YrwQ
(envelope-from <editor@clincasereportintle.com>)
for <ithome@host100322.itwesthosting.com>; Thu, 11 Sep 2025 19:22:45 +0200
Return-path: <editor@clincasereportintle.com>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Thu, 11 Sep 2025 19:22:45 +0200
Received: from eb9.articles.vcomailer.com ([193.29.14.108]:38281)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <editor@clincasereportintle.com>)
id 1uwl0O-000710-1s
for senka.rendulic@bolnica-lipik.hr;
Thu, 11 Sep 2025 19:22:45 +0200
DKIM-Signature: v=1; a=rsa-sha256;
bh=5T2lANV8W7Vmv+HskwBl7zoJrq4Cy6mk46x2Qe7Z2jQ=; d=clincasereportintle.com;
h=Message-ID: Date: Subject: From: Reply-To: To: MIME-Version: Content-Type:
List-Unsubscribe-Post: List-Unsubscribe: List-Id: Feedback-ID;
i=@clincasereportintle.com; s=mailer; c=relaxed/relaxed; t=1757611358;
b=SH/gVa6Ta7EbLmB94aKYvdNgIP2B51zRFa4Jf78x3uJhLJ3XVyB9ew//kA8c5mNXPljmRSf2T
+vo7NPkg6/nHebkaNI/+2w9y0yIsHsSglzjaBYcWfQd7cjlPHr7LQvU1lJsH50Q6E6oRV5+FC
9HW/N3uUHSoLVbF3NxB8SG7v0M2kLghMaMP6fJCZCymaDCFYqbLQF/sxiUAIOODYY2pDTYgBu
xV+/SUikDRzr55PUWHEa7JKrzfdoPR1V4mdURb8j08BdmfPWJNVjCn8hz1S0UWvvdnk7+NmWY
qO+EHESgmHDPzG2EdBn0juVVJqCgPtRHkyOHeELjqlECJMPvwQ==
Message-ID: <67b3f6cb9632c69b1b033da98e2d38577d6da238@clincasereportintle.com>
Date: Thu, 11 Sep 2025 17:22:38 +0000
From: Clinical Case Reports International (ISSN 2638-4558)
<editor@clincasereportintle.com>
Reply-To: Clinical Case Reports International (ISSN 2638-4558)
<anneblake@caserepint.com>
To: "senka.rendulic@bolnica-lipik.hr" <senka.rendulic@bolnica-lipik.hr>
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="_=_swift_1757611358_eadd9612490c08e01d29c24a165a1e0d_=_"
X-Report-Abuse: http://172.237.133.33/mail/index.php/campaigns/wh186pqbqm78a/report-abuse/pf453x2lf1acd/og791mb5qr737
X-EBS: http://172.237.133.33/mail/index.php/lists/block-address
List-Unsubscribe-Post: List-Unsubscribe=One-Click
List-Unsubscribe: <http://172.237.133.33/mail/index.php/lists/pf453x2lf1acd/unsubscribe/og791mb5qr737/wh186pqbqm78a?source=email-client-unsubscribe-button>,
<mailto:anneblake@caserepint.com?subject=Campaign-Uid%3Awh186pqbqm78a%20%2F%20Subscriber-Uid%3Aog791mb5qr737%20-%20Unsubscribe%20request&body=Please%20unsubscribe%20me%21>
List-Id: pf453x2lf1acd <CFP 01>
Feedback-ID: wh186pqbqm78a:og791mb5qr737:pf453x2lf1acd:cj8170797z5a7
X-Spam-Status: Yes, score=9.6
X-Spam-Score: 96
X-Spam-Bar: +++++++++
X-Spam-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has identified this incoming email as possible spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: DEAR PROF. SENKA RENDULI? SLIVAR, I am reaching out to personally
INVITE YOU TO SUBMIT YOUR CASE REPORT FOR OUR UPCOMING ISSUE (VOLUME 9 ISSUE
4), scheduled for release by SEP 30, 2025. Your expertise in treating rare
medical conditions is highly valued, and we believe your work would be an
excellent addition to our journal. Whether it’s ORIGINAL RESEARCH, a REVIEW
ARTICLE, CASE RE [...]
Content analysis details: (9.6 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: clincasereportintle.com]
4.5 URIBL_DBL_SPAM Contains a spam URL listed in the Spamhaus DBL
blocklist
[URIs: clincasereportintle.com]
0.3 URIBL_CT_SURBL Contains an URL listed in the CT SURBL blocklist
[URIs: 172.237.133.33]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[193.29.14.108 listed in bl.score.senderscore.com]
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[193.29.14.108 listed in sa-trusted.bondedsender.org]
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 NORMAL_HTTP_TO_IP URI: URI host has a public dotted-decimal IPv4
address
0.0 NUMERIC_HTTP_ADDR URI: Uses a numeric IP address in URL
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
2.4 RAZOR2_CF_RANGE_51_100 Razor2 gives confidence level above 50%
[cf: 100]
1.7 RAZOR2_CHECK Listed in Razor2 (http://razor.sf.net/)
0.8 FROM_FMBLA_NEWDOM28 From domain was registered in last 14-28
days
X-Spam-Flag: YES
Subject: ***SPAM*** Prof. Senka Renduli? Slivar - Clinical Case Reports International
(ISSN 2638-4558)
X-From-Rewrite: unmodified, forwarded message
--_=_swift_1757611358_eadd9612490c08e01d29c24a165a1e0d_=_
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: quoted-printable
DEAR PROF. SENKA RENDULI? SLIVAR,
I am reaching out to personally INVI=
TE YOU TO SUBMIT YOUR CASE REPORT
FOR OUR UPCOMING ISSUE (VOLUME 9 ISSUE =
4), scheduled for release by
SEP 30, 2025.
Your expertise in treatin=
g rare medical conditions is highly valued,
and we believe your work woul=
d be an excellent addition to our
journal. Whether it=E2=80=99s ORIGINAL =
RESEARCH, a REVIEW ARTICLE, CASE
REPORTS, or CLINICAL IMAGES/VIDEOS, we w=
ould be honoured to consider
your submission for publication.
CLINIC=
AL CASE REPORTS INTERNATIONAL (CCRI) offers a 10-14 DAY
FAST-TRACK PEER R=
EVIEW process, and accepted articles are published
online WITHIN 72 HOURS=
. Additionally, every article receives a DOI
ISSUED BY CROSSREF and is in=
dexed on renowned medical databases
ensuring global visibility and impact=
factor.
To submit your manuscript, please follow the link below: =
=F0=9F=91=89 SUBMIT
YOUR MANUSCRIPT HERE
[http://172.237.133.33/mail/in=
dex.php/campaigns/wh186pqbqm78a/track-url/og791mb5qr737/962058a0c7e9f8a3686=
ac0c2b7dbb963b3f395c3]
Thank you for considering CCRI for your importa=
nt work. We look
forward to your submission.
Best regards,
ANNE BL=
AKE
Senior Editor
Editorial Office
_Clinical Case Reports Internation=
al_
ISSN: 2638-4558 | United States
_To stop receiving further email=
s from us, please reply with
=E2=80=9CUnsubscribe.=E2=80=9D_
=C2=A0
--_=_swift_1757611358_eadd9612490c08e01d29c24a165a1e0d_=_
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: quoted-printable
<!DOCTYPE html>
<html>
<head><meta charset=3D"utf-8"/>
=09<title>Prof. Senka Renduli? Slivar - Clinical Case Reports International=
(ISSN 2638-4558)</title>
</head>
<body><span style=3D"font-size:11pt"><span style=3D"line-height:normal"><sp=
an style=3D"font-family:Cambria,serif"><b><span style=3D"font-family:"=
Times New Roman",serif">Dear Prof. Senka Renduli? Slivar,</span></b><b=
r />
<br />
<span style=3D"font-size:12.0pt"><span style=3D"font-family:"Times New=
Roman",serif">I am reaching out to personally <b>invite you to submit=
your case report for our upcoming issue</b> <b>(Volume 9 Issue 4)</b>, sch=
eduled for release by <b>Sep 30, 2025</b>.</span></span></span></span></spa=
n><br />
<br />
<span style=3D"font-size:11pt"><span style=3D"line-height:normal"><span sty=
le=3D"font-family:Cambria,serif"><span style=3D"font-size:12.0pt"><span sty=
le=3D"font-family:"Times New Roman",serif">Your expertise in trea=
ting rare medical conditions is highly valued, and we believe your work wou=
ld be an excellent addition to our journal. Whether it=E2=80=99s <b>origina=
l research</b>, a <b>review article</b>, <b>case reports</b>, or <b>clinica=
l images/videos</b>, we would be honoured to consider your submission for p=
ublication.</span></span></span></span></span><br />
<br />
<span style=3D"font-size:11pt"><span style=3D"line-height:normal"><span sty=
le=3D"font-family:Cambria,serif"><b><span style=3D"font-size:12.0pt"><span =
style=3D"font-family:"Times New Roman",serif">Clinical Case Repor=
ts International</span></span></b><span style=3D"font-size:12.0pt"><span st=
yle=3D"font-family:"Times New Roman",serif"> (CCRI) offers a <b>1=
0-14 day fast-track peer review</b> process, and accepted articles are publ=
ished online <b>within 72 hours</b>. Additionally, every article receives a=
<b>DOI issued by CrossRef</b> and is indexed on renowned medical databases=
ensuring global visibility and impact factor.</span></span></span></span><=
/span><br />
<br />
<span style=3D"font-size:11pt"><span style=3D"line-height:normal"><span sty=
le=3D"font-family:Cambria,serif"><span style=3D"font-size:12.0pt"><span sty=
le=3D"font-family:"Times New Roman",serif">To submit your manuscr=
ipt, please follow the link below: </span></span><span style=3D"font-size:1=
2.0pt"><span style=3D"font-family:"Segoe UI Emoji",sans-serif">&#=
x1f449;</span></span> <a href=3D"http://172.237.133.33/mail/index.php/campa=
igns/wh186pqbqm78a/track-url/og791mb5qr737/962058a0c7e9f8a3686ac0c2b7dbb963=
b3f395c3" style=3D"color:blue; text-decoration:underline"><b><span lang=3D"=
EN-IN" style=3D"font-size:12.0pt"><span style=3D"font-family:"Times Ne=
w Roman",serif">Submit your manuscript here</span></span></b></a></spa=
n></span></span><br />
<br />
<span style=3D"font-size:11pt"><span style=3D"line-height:normal"><span sty=
le=3D"font-family:Cambria,serif"><span style=3D"font-size:12.0pt"><span sty=
le=3D"font-family:"Times New Roman",serif">Thank you for consider=
ing <b>CCRI</b> for your important work. We look forward to your submission=
.</span></span></span></span></span><br />
<br />
<br />
<span style=3D"font-size:11pt"><span style=3D"line-height:normal"><span sty=
le=3D"font-family:Cambria,serif"><span style=3D"font-size:12.0pt"><span sty=
le=3D"font-family:"Times New Roman",serif">Best regards,<br />
<b>Anne Blake</b><br />
Senior Editor<br />
Editorial Office<br />
<i>Clinical Case Reports International</i><br />
ISSN: 2638-4558 | United States</span></span></span></span></span><br />
<br />
<br />
<br />
<br />
<br />
<span style=3D"font-size:11pt"><span style=3D"line-height:normal"><span sty=
le=3D"font-family:Cambria,serif"><i><span style=3D"font-size:12.0pt"><span =
style=3D"font-family:"Times New Roman",serif">To stop receiving f=
urther emails from us, please reply with =E2=80=9CUnsubscribe.=E2=80=9D</sp=
an></span></i></span></span></span><br />
=C2=A0<img width=3D"1" height=3D"1" src=3D"http://172.237.133.33/mail/index=
.php/campaigns/wh186pqbqm78a/track-opening/og791mb5qr737" alt=3D"" />
</b=
ody>
</html>
--_=_swift_1757611358_eadd9612490c08e01d29c24a165a1e0d_=_--